How are we treating our systemic patients with primary Sjögren syndrome? Analysis of 1120 patients

dc.contributor.author	Gheitasi, H.
dc.contributor.author	Kostov, B.
dc.contributor.author	Solans, R.
dc.contributor.author	Díaz López, José Bernardino
dc.contributor.author	Autoimmune Diseases Study Group (GEAS)
dc.date.accessioned	2015-12-21T10:40:08Z
dc.date.available	2015-12-21T10:40:08Z
dc.date.issued	2015
dc.identifier.citation	International Immunopharmacology, 27(2), p. 194, 3610-199 (2015); doi:10.1016/j.intimp.2015.03.027
dc.identifier.issn	1567-5769
dc.identifier.uri	http://hdl.handle.net/10651/34235
dc.description.statementofresponsibility	Gheitasi, H., Kostov, B., Solans, R., Fraile, G., Suárez-Cuervo, C., Casanovas, A., Rascón, F.J., Qanneta, R., Pérez-Alvarez, R., Ripoll, M., Akasbi, M., Pinilla, B., Bosch, J.A., Nava-Mateos, J., Díaz-López, B., Morera-Morales, M.L., Retamozo, S., Ramos-Casals, M., Brito-Zerón, P., Spanish Society of Internal Medicine (SEMI), SS Study Group
dc.format.extent	p. 194, 3610-199
dc.language.iso	eng
dc.relation.ispartof	International Immunopharmacology
dc.rights	© 2015 Elsevier B.V.
dc.source	Scopus
dc.source.uri	http://www.scopus.com/inward/record.url?eid=2-s2.0-84937164886&partnerID=40&md5=0d47b5f62e38701ace8b05ae09ba7053
dc.title	How are we treating our systemic patients with primary Sjögren syndrome? Analysis of 1120 patients
dc.type	journal article
dc.identifier.doi	10.1016/j.intimp.2015.03.027
dc.relation.publisherversion	http://dx.doi.org/10.1016/j.intimp.2015.03.027

Ficheros en el ítem

Ficheros	Tamaño	Formato	Ver
No hay ficheros asociados a este ítem.